Fertility After Breast Cancer

3

Young women may think about having children, but when diagnosed with breast cancer, patients often face these decisions long before they thought they would have to.

Maggie Loucks, NP-C

Maggie Loucks, NP-C

For Maggie Loucks, NP-C, who was diagnosed at age 28, preserving fertility became a major factor in deciding what treatment plan to pursue.

“You’re 28-years old and you want to do everything you can to ensure this doesn’t come back, but at the same time you want to preserve your fertility as much as possible,” says Loucks, who sought care at the Susan F. Smith Center for Women’s Cancers at Dana-Farber.

Although the process was stressful, Loucks says she was fortunate to be part of the Program for Young Women with Breast Cancer, as well as Dana-Farber’s Young Adult Program, which provided resources and support.

“Dealing with this potential loss of fertility can lead to intense emotions, like sadness and anger. Getting good, clear information and a realistic sense of what may or may not be possible often helps,” says Ann Partridge, MD, Loucks’ oncologist and the founder/director of the Program for Young Women with Breast Cancer.

Loucks worked with Partridge to develop a plan that would be effective but also allow her to have a family in the future. Because breast feeding was important to her, Loucks decided to get a lumpectomy instead of a mastectomy. She was also referred to the Reproductive Endocrinology Group at Brigham and Women’s Hospital to discuss options to ensure fertility preservation, and decided to harvest embryos in the four weeks between her surgery and the start of her chemotherapy.

For Loucks, there was a choice between a new regimen to treat her cancer that was less likely to affect her future fertility, and a more standard regimen that was much more likely to decrease fertility, which Partridge calls “kitchen-sink” chemotherapy.  Based on Loucks’ preferences and concerns as a young woman with breast cancer, and because Loucks did not have a high risk tumor, she and Partridge chose a treatment plan that included an effective chemotherapy with less risk for infertility.

Some cancer treatments, such as the hormonal therapy Tamoxifen, do not damage the ovaries, while standard chemotherapy can often damage the ovaries directly and reduce fertility. If treatment does affect fertility, patients have several other options they can pursue, Partridge says:

  • Cryopreservation involves embryo freezing, freezing an unfertilized egg (a less successful method) or freezing ovarian tissue (a method that is highly experimental).
  • Medical ovarian suppression, which recent data has suggested is effective, involves hormone shots during cancer treatment to shut down ovaries so that they may be protected from chemotherapy.
  • Using donor embryos or donor eggs after treatment.

In cancer care, one size does not fit all and although her treatment plan may not be the most aggressive, Loucks said she was grateful that Partridge knows there are a lot more factors than just getting rid of the cancer.

“My original life plan was a little bit derailed but I’m very lucky to be where I am now under the care of Dr. Partridge and Dana-Farber,” says Loucks, who is now a nurse in Dana-Farber’s Center for Sarcoma and Bone Oncology.

Two years after her diagnosis, Loucks is taking advantage of her free time until her treatment ends and she can focus once again on starting a family.

Comments Sort By Newest

3 thoughts on “Fertility After Breast Cancer

  1. I am so happy to see this topic getting attention, and am very happy that Maggie and other young women are given the chance to choose fertility preserving options! However, I was very disappointed not to see any mention of adoption after breast cancer. Adoption for me was the right choice and should at least be offered for consideration, as a medically non-invasive option for women who are eager to grow their family and don’t want to wait the five years (or now ten years??) until tamoxifen is finished. I was diagnosed and treated for hormone positive breast cancer twice, once at age 32 and again at 37. My husband and I thoroughly researched fertility preservation upon my initial diagnosis, but ultimately decided in favor of adoption. My beautiful son is now four years old and we cannot imagine life without him! Dr. Partridge, please add adoption to your bulleted list of “several other options they can pursue.” Women need to understand that they need not choose between potentially life-saving maintenance treatment for breast-cancer and parenthood. They can have both. I do, and I am happy. Just because breast cancer treatment may (unfairly) close the door to women wanting to have a biological child, the door to motherhood is most certainly NOT closed.

    • Dear Jean —
      Thank you for your thoughtful comment and for reading our Insight blog. You make a great point about adoption as an option for parenthood. We have passed your comment along to Dr. Partridge and we will be sure to highlight adoption in future posts. Thank you again!

  2. Maggie,
    You are a true inspiration to all patients at Dana-Farber Institute. I for one will always give thanks for having you as a Professional provider. I will pray for you and never forget you as long as I am on the green side of the grass. God Bless you young lady. Hans

  3. Maggie,
    You are a true inspiration to all patients at Dana-Farber Institute. I for one will always give thanks for having you as a Professional provider. I will pray for you and never forget you as long as I am on the green side of the grass. God Bless you young lady. Hans

  4. I am so happy to see this topic getting attention, and am very happy that Maggie and other young women are given the chance to choose fertility preserving options! However, I was very disappointed not to see any mention of adoption after breast cancer. Adoption for me was the right choice and should at least be offered for consideration, as a medically non-invasive option for women who are eager to grow their family and don’t want to wait the five years (or now ten years??) until tamoxifen is finished. I was diagnosed and treated for hormone positive breast cancer twice, once at age 32 and again at 37. My husband and I thoroughly researched fertility preservation upon my initial diagnosis, but ultimately decided in favor of adoption. My beautiful son is now four years old and we cannot imagine life without him! Dr. Partridge, please add adoption to your bulleted list of “several other options they can pursue.” Women need to understand that they need not choose between potentially life-saving maintenance treatment for breast-cancer and parenthood. They can have both. I do, and I am happy. Just because breast cancer treatment may (unfairly) close the door to women wanting to have a biological child, the door to motherhood is most certainly NOT closed.

    1. Dear Jean —
      Thank you for your thoughtful comment and for reading our Insight blog. You make a great point about adoption as an option for parenthood. We have passed your comment along to Dr. Partridge and we will be sure to highlight adoption in future posts. Thank you again!

Comments are closed.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
Basic, Clinical and Translational Research: What’s the Difference? https://t.co/y42sqY2lZk #research https://t.co/uwgS13YdDq
Dana-Farber @danafarber
RT @ASH_hematology: ASH thanks 2017 President Kenneth Anderson, MD, of @DanaFarber for his leadership and service to the Society #ASH17 htt…
Dana-Farber @danafarber
Congratulations to Dana-Farber/@BrighamWomens’ Dr. Benjamin Ebert, recipient of the William Dameshek Prize, awarded… https://t.co/cG7FjvRBHC

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.